 |
|
|
| |
Resistance Analysis of Long-Acting Lenacapavir in Highly Treatment-Experienced People With HIV After 52 Weeks of Treatment
|
| |
| |
AIDS 2022 July 29 - Aug 1 Montreal
Nicolas Margot, Laurie VanderVeen, Vidula Naik, Hadas Dvory-Sobol, Martin S. Rhee, Christian Callebaut - Gilead Sciences, Inc., Foster City, California, USA
|
| |
|
|
|
|
|
